EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+39.94%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.39B
AUM Growth
+$509M
(+18%)
Cap. Flow
-$97.3M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
67.93%
Holding
88
New
8
Increased
10
Reduced
15
Closed
11
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$98.7M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$70.9M |
| 3 |
Gossamer Bio
GOSS
|
$49.8M |
| 4 |
Kymera Therapeutics
KYMR
|
$17.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$14.5M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$98.9M |
| 2 |
Revolution Medicines
RVMD
|
$48.8M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$48.7M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$43.5M |
| 5 |
argenx
ARGX
|
$37.9M |
Sector Composition
| 1 | Healthcare | 99.31% |
| 2 | Financials | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Adverum Biotechnologies
ADVM
$68.2M
| – | – |
-104,670
| Closed | -$1.26M |
|
77
Bolt Biotherapeutics
BOLT
$9.29M
| – | – |
-7,500
| Closed | -$306K |
|
78
Celldex Therapeutics
CLDX
$1.57B
| – | – |
0
| – | – |
|
79
Dyne Therapeutics
DYN
$1.92B
| – | – |
-215,000
| Closed | -$1.48M |
|
80
Exelixis
EXEL
$9.95B
| – | – |
0
| – | – |
|
81
Incyte
INCY
$17B
| – | – |
-182,783
| Closed | -$13.9M |
|
82
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-12,438
| Closed | -$1.44M |
|
83
Olema Pharmaceuticals
OLMA
$432M
| – | – |
-353,701
| Closed | -$1.44M |
|
84
ARS Pharmaceuticals
SPRY
$1.08B
| – | – |
-575,359
| Closed | -$2.44M |
|
|
VERV
85
DELISTED
Verve Therapeutics
VERV
| – | – |
-98,593
| Closed | -$1.51M |
|
|
CERE
86
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| – | – |
-1,646,260
| Closed | -$43.5M |
|
|
PRDS
87
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – |
-200,000
| Closed | -$614K |
|
|
EVLO
88
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| – | – |
-10,021
| Closed | -$423K |
|